Cas No.: | 1448237-05-5 |
Chemical Name: | 6-Ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-(((3R)-1-(1-oxoprop-2-en-1-yl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide monomethanesulfonate |
Synonyms: | ASP8273; ASP-8273; ASP 8273; ASP8273 mesilate; Naquotinib mesylate |
SMILES: | O=C(N)C1C(NC2C=CC(N3CCC(N4CCN(C)CC4)CC3)=CC=2)=NC(OC2CCN(C(=O)C=C)C2)=C(CC)N=1.CS(=O)(O)=O |
Formula: | C31H46N8O6S |
M.Wt: | 658.819 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR (IC50=8-33 nM for (L858R, exon 19 deletion, L858R/T790M, and del19/T790M)); more potently than that of WT EGFR (IC50= 230 nM); shows activity in mutant EGFR cell line which is resistant to other EGFR TKIs including AZD9291 and CO-1686.Lung CancerPhase 3 Clinical |